Abstract
Endocardial fibroelastosis (EFE) is commonly considered to be an inflammatory reactive lesion of hyperplasia and deposition of tissue fibers and collagen in the endocardium and/or subendocardium, which is strongly associated with endocardial sclerosis, ventricular remodeling and acute and chronic heart failure, and is one of the important causes for pediatric heart transplantation. Early diagnosis and treatment are the key factors in determining the prognosis of the children. In this paper, we would like to highlight the potential unintended consequences of the use of sedation and biopsy for pediatric acute heart failure caused by EFE and the comprehensive considerations prior to clinical diagnosis.
| Original language | English |
|---|---|
| Pages (from-to) | 5412-5415 |
| Journal | World Journal of Clinical Cases |
| Volume | 11 |
| Issue number | 22 |
| Online published | 6 Aug 2023 |
| DOIs | |
| Publication status | Published - 6 Aug 2023 |
| Externally published | Yes |
Research Keywords
- Endocardial fibroelastosis
- Sedation in children
- Endomyocardial biopsy
- Comprehensive clinical diagnosis
Publisher's Copyright Statement
- This full text is made available under CC-BY-NC 4.0. https://creativecommons.org/licenses/by-nc/4.0/
Fingerprint
Dive into the research topics of 'Caution in the use of sedation and endomyocardial biopsy for the management of pediatric acute heart failure caused by endocardial fibroelastosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver